SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-149524
Filing Date
2019-05-16
Accepted
2019-05-16 17:01:02
Documents
3
Period of Report
2019-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d735779d8k.htm 8-K 18821
2 EX-99.1 d735779dex991.htm EX-99.1 57058
3 GRAPHIC g735779g0516235533453.jpg GRAPHIC 4607
  Complete submission text file 0001193125-19-149524.txt   83515
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38853 | Film No.: 19833138
SIC: 2834 Pharmaceutical Preparations